Found 17 matching trials
Evaluating the Safety and Immune Response to Five Different Combinations of HIV Vaccines in Healthy, HIV-Uninfected Adults PHASE1 This study will evaluate the safety and immune response to five different c...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluating the Safety and Immune Response to Different Combinations of the DNA-HIV-PT123 and AIDSVAX® B/E Vaccines in Healthy, HIV-Uninfected Adults PHASE1 This study will evaluate the safety, tolerability, and immune response to d...
Show More Learn More & Join Trial
A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP PHASE2 This international, multi-centre, double-blind vaccine study is a three-arm...
Show More Location
MRC/UVRI and LSHTM Uganda Research Unit
Learn More & Join Trial
Evaluating the Immunogenicity of the AIDSVAX B/E Vaccine and the MVA/HIV62B Vaccine in Healthy, HIV-1-Uninfected Adults Who Previously Received MVA/HIV62B in DNA/MVA or MVA/MVA Regimens in HVTN 205 PHASE1 The purpose of this study is to evaluate the safety, tolerability, and immu...
Show More Learn More & Join Trial
Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E PHASE2 The primary purpose of the study is to better define the relative contribut...
Show More Location
Royal Thai Army Clinical Research Center, AFRIMS
Learn More & Join Trial
HIV Vaccine in HIV-uninfected Adults PHASE1 The purpose of this study is to test whether delayed boosting (an extra adm...
Show More Location
Armed Forces Research Institute of Medical Sciences
Learn More & Join Trial
Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults PHASE1 The HIV Vaccine Trials Network (HVTN) is doing a study to test 2 experiment...
Show More Location
Emavundleni Desmond Tutu HIV Centre CRS
Learn More & Join Trial
A Safety and Immune Response Study of 2 Experimental HIV Vaccines PHASE1 The HIV Vaccine Trials Network (HVTN) is doing a study to test a new HIV va...
Show More Location
CAPRISA eThekwini CRS
Learn More & Join Trial
RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV PHASE1 This is a phase I, randomized, double-blind, placebo-controlled clinical tr...
Show More Location
The Faculty of Medicine, Chulalongkorn University/ King Chulalongkorn Memorial Hospital
Learn More & Join Trial
Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients PHASE2 Prior pilot studies have shown that four monthly injections of ALVAC-HIV (v...
Show More Location
Northwestern University Medical School
Learn More & Join Trial